Article Details

Libtayo® (cemiplimab) Receives Positive CHMP Opinion Recommending Approval to Treat ...

Retrieved on: 2022-10-14 20:57:20

Tags for this article:

Click the tags to see associated articles and topics

Libtayo® (cemiplimab) Receives Positive CHMP Opinion Recommending Approval to Treat .... View article details on HISWAI: https://www.biospace.com/article/releases/libtayo-cemiplimab-receives-positive-chmp-opinion-recommending-approval-to-treat-advanced-cervical-cancer/

Excerpt

Libtayo is a fully human monoclonal antibody targeting the immune ... humanized immune system to produce optimized fully human antibodies.

Article found on: www.biospace.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up